Chronic myelomonocytic leukemia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

2FDA treatments

25Recruiting trials

Regulatory Watchboard

10 events

Mar 2026Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — EARLY_PHASE1

TrialRECRUITING

Jan 2026A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

BioLite, Inc. — PHASE2

TrialNOT YET RECRUITING

Aug 2025The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes

Peking University People's Hospital

TrialNOT YET RECRUITING

Apr 2025Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

City of Hope Medical Center — PHASE2

TrialRECRUITING

Jan 2025A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

M.D. Anderson Cancer Center — PHASE2

TrialRECRUITING

Jan 2025Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

City of Hope Medical Center — PHASE1

TrialRECRUITING

Nov 2024IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. — PHASE3

TrialRECRUITING

Apr 2024Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

Fox Chase Cancer Center — PHASE1

TrialRECRUITING

Dec 2023A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

Otsuka Australia Pharmaceutical Pty Ltd — PHASE3

TrialACTIVE NOT RECRUITING

Oct 2023Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

Groupe Francophone des Myelodysplasies — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Chronic myelomonocytic leukemia.
Check the disease page for updates →

Approved Treatments

2 FDA-approved

Azacitidine

(AZACITIDINE FOR)Orphan drugstandard

Pilnova Pharma Inc

Nucleoside Metabolic Inhibitor [EPC]

12.1 Mechanism of Action Azacitidine is a pyrimidine nucleoside analog of cytidine. Azacitidine is believed to exert its antineoplastic effects by cau...

Azacitidine

(AZACITIDINE)Orphan drugstandard

Dr. Reddy's Laboratories Inc.

Nucleoside Metabolic Inhibitor [EPC]

12.1 Mechanism of Action Azacitidine for injection is a pyrimidine nucleoside analog of cytidine. Azacitidine for injection is believed to exert its a...

View full treatment details on disease page →

Clinical Trial Landscape

25 active trials

4Phase 3

9Phase 2

5Phase 1

6PHASE1, PHASE2

1EARLY_PHASE1

25Total recruiting

Search clinical trials for Chronic myelomonocytic leukemia →

Recent News & Research

No recent news articles indexed yet for Chronic myelomonocytic leukemia.
Search PubMed for Chronic myelomonocytic leukemia →

Browse all Chronic myelomonocytic leukemia news →

Specialist Network

Top 6 by expertise

Hagop Kantarjian, MD, MD

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 397 trials

Naval Daver, MD, MBBS

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 308 trials

Farhad Ravandi-Kashani, MD, M.D

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 198 trials

Jorge Cortes, MD

UT MD Anderson Cancer Center

Score 1917 trials

Abhay Singh, MD, MPH

Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute

📍 Cleveland, Ohio

Score 121 trial

Bart Scott

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 103 trials

View all Chronic myelomonocytic leukemia specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles